MANUEL
DELGADO ALVARADO
Ikertzailea 2022-(e)ra arte
Hospital Universitario Quirónsalud Madrid
Madrid, EspañaHospital Universitario Quirónsalud Madrid-ko ikertzaileekin lankidetzan egindako argitalpenak (2)
2023
2021
-
Does Extended Interval Dosing Natalizumab Preserve Effectiveness in Multiple Sclerosis? A 7 Year-Retrospective Observational Study
Frontiers in Immunology, Vol. 12